Restricted accessResearch articleFirst published online 2026
Integrated or Parallel Configurations for Renal Replacement Therapy in Patients on VenoArterial Extracorporeal Membrane Oxygenation,a Single Center Retrospective Study
Acute kidney injury (AKI) is frequent in patients supported with venoarterial extracorporeal membrane oxygenation (VA-ECMO), largely due to the severity of cardiogenic shock and multiorgan failure. Renal replacement therapy (RRT) can be delivered either via an indwelling catheter (parallel system, PS) or through direct connection to the ECMO circuit (integrated system, IS). Their respective safety profiles, particularly regarding infectious, hemorrhagic, and circuit-related complications, remain insufficiently characterized.
Methods
We conducted a single-center retrospective analysis of prospectively collected data from consecutive adults who received RRT for ≥24 h while on VA-ECMO between 2006 and 2019. Complications occurring during the concomitant ECMO–RRT period were compared between IS and PS configurations.
Results
Eighty patients (84 procedures: 42 IS, 42 PS) were included. Infectious complications occurred in 31% of IS procedures and 45.2% of PS procedures, with earlier onset in the PS group (3 vs 5 days; p = 0.048). However, in multivariable analysis, IS was not independently associated with reduced infection risk (OR 0.67 [0.27-1.70]; p = 0.421). Hemorrhagic events (54.8% IS vs 59.5% PS) and circuit dysfunctions, including filter clotting, were comparable between groups.
Conclusion
In VA-ECMO patients requiring RRT, integrated and parallel configurations demonstrate similar safety profiles with no significant differences in infectious, hemorrhagic, or circuit-related complications. These findings support selecting the RRT configuration based primarily on local expertise and technical feasibility rather than expected differences in complication risk
FlecherEAnselmiACorbineauH, et al.Current aspects of extracorporeal membrane oxygenation in a tertiary referral centre: Determinants of survival at follow-up. Eur J Cardiothorac Surg. 1 oct 2014;46(4):665-671.
2.
SmithMVukomanovicABrodieDThiagarajanRRycusPBuscherH. Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: An analysis of the extracorporeal life support organization (ELSO) registry. Crit Care. 6 mars 2017;21(1):45.
3.
ThieleHZeymerUAkinI, et al.Extracorporeal life support in infarct-related cardiogenic shock. N Engl J Med. 26 août 2023;389(14):1286-1297.
4.
SheuJJTsaiTHLeeFY, et al.Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med. 2010;38(9):1810-1817.
5.
ChenYSLinJWYuHY, et al.Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: An observational study and propensity analysis. Lancet.août 2008;372(9638):554-561.
6.
AyersBBjelicMKumarN, et al.Long-term renal function after venoarterial extracorporeal membrane oxygenation. J Card Surg. 2021;36(3):815-820.
7.
AskenaziDJSelewskiDTPadenML, et al.Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clin J Am Soc Nephrol CJASN. août 2012;7(8):1328-1336.
8.
FotiLVillaGRomagnoliSRicciZ. Acute kidney injury and extracorporeal membrane oxygenation: Review on multiple organ support options. Int J Nephrol Renov Dis. August 2021;13(14):321-329.
9.
RajsicSTremlBJadzicD, et al.Extracorporeal membrane oxygenation for cardiogenic shock: A meta-analysis of mortality and complications. Ann Intensive Care. 5 oct 2022;12(1):93.
10.
ThajudeenBKamelMArumugamC, et al.Outcome of patients on combined extracorporeal membrane oxygenation and continuous renal replacement therapy: A retrospective study. Int J Artif Organs. 3 févr 2015;38(3):133-137.
11.
AntonucciELamannaIFagnoulDVincentJLDe BackerDSilvio TacconeF. The impact of renal failure and renal replacement therapy on outcome during extracorporeal membrane oxygenation therapy. Artif Organs. 2016;40(8):746-754.
12.
DammanKvan DeursenVMNavisGVoorsAAvan VeldhuisenDJHillegeHL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 17 févr 2009;53(7):582-588.
13.
MullensWAbrahamsZFrancisGS, et al.Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 17 févr 2009;53(7):589-596.
14.
VinodPKrishnappaVChauvinAMKhareARainaR. Cardiorenal syndrome: Role of arginine vasopressin and vaptans in heart failure. Cardiol Res. 2017;8(3):87-95.
15.
SchrierRWAbrahamWT. Hormones and hemodynamics in heart failure. N Engl J Med. 19 août 1999;341(8):577-585.
16.
GunningSKutubyFRoseRTrevinoSSongTKoynerJL. Fluid overload and mortality in patients with severe acute kidney injury and extracorporeal membrane oxygenation. Kidney360. 25 mars 2020;1(4):232-240.
17.
Husain-SyedFRicciZBrodieD, et al.Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: From native to artificial organ crosstalk. Intensive Care Med. 1 sept 2018;44(9):1447-1459.
18.
SelewskiDTWilleKM. Continuous renal replacement therapy in patients treated with extracorporeal membrane oxygenation. Semin Dial. 2021;34(6):537-549.
19.
JacobsRHonorePMSpapenHD. Intertwining extracorporeal membrane oxygenation and continuous renal replacement therapy: Sense or nonsense?Crit Care. 2015;19(1):145.
20.
FlemingGMAskenaziDJBridgesBC, et al.A multicenter international survey of renal supportive therapy during ECMO: The kidney intervention during extracorporeal membrane oxygenation (KIDMO) group. ASAIO J Am Soc Artif Intern Organs. 1992. 2012;58(4):407-414.
21.
BidarFLuytCESchneiderA, et al.Renal replacement therapy in extra-corporeal membrane oxygenation patients: A survey of practices and new insights for future studies. Anaesth Crit Care Pain Med. déc 2021;40(6):100971.
22.
SchmidtMCombesA. Complications infectieuses sous ECMO. Médecine Intensive Réanimation. 23 mars 2015;24(3):265-269.
23.
FrerouALesouhaitierMGregoireM, et al.Venoarterial extracorporeal membrane oxygenation induces early immune alterations. Crit Care. déc 2021;25(1):9.
24.
TadiéJMGacouinATulzoYL. Dysfonction immunitaire induite par la ventilation mécanique. Médecine Intensive Réanimation. 11 janv 2014;23(1):9-16.
25.
SidebothamDMcGeorgeAMcGuinnessSEdwardsMWillcoxTBecaJ. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: Part 2-technical considerations. J Cardiothorac Vasc Anesth. févr 2010;24(1):164-172.
26.
TanCSTanHKChoongHL. Real-time circuit pressures correlate poorly with circuit longevity in anticoagulant-free, predilution continuous venovenous hemofiltration. Blood Purif. 2011;32(1):15-20.
27.
LiCWangHLiuNJiaMHouX. The effect of simultaneous renal replacement therapy on extracorporeal membrane oxygenation support for postcardiotomy patients with cardiogenic shock: A pilot randomized controlled trial. J Cardiothorac Vasc Anesth. 1 nov 2019;33(11):3063-3072.
28.
ThongprayoonCCheungpasitpornWLertjitbanjongP, et al.Incidence and impact of acute kidney injury in patients receiving extracorporeal membrane oxygenation: A meta-analysis. J Clin Med. 5 juill 2019;8(7):981.
29.
MitraSLingRRTanCSShekarKMacLarenGRamanathanK. Concurrent use of renal replacement therapy during extracorporeal membrane oxygenation support: A systematic review and meta-analysis. J Clin Med. janv 2021;10(2):241.
30.
ChenHYuRGYinNNZhouJX. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: A systematic review. Crit Care Lond Engl. 8 déc 2014;18(6):675.
31.
WorkuBKhinSGaudinoM, et al.Renal replacement therapy in patients on extracorporeal membrane oxygenation support: Who and how. Int J Artif Organs. 1 août 2021;44(8):531-538.
32.
LesouhaitierMUhelFGregoireM, et al.Monocytic myeloid-derived suppressor cell expansion after cardiac surgery with cardiopulmonary bypass induces lymphocyte dysfunction. Shock. déc 2022;58(6):476-483.
33.
HübnerMTomasiREffingerD, et al.Myeloid-Derived suppressor cells mediate immunosuppression after cardiopulmonary bypass. Crit Care Med. août 2019;47(8):e700-e709.
34.
SchmidtMBrechotNHaririS, et al.Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clin Infect Dis. 15 déc 2012;55(12):1633-1641.
35.
O’GradyNPAlexanderMBurnsLA, et al.Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. mai 2011;39(4):S1-34.
36.
ZeidmanAD. Extracorporeal membrane oxygenation and continuous kidney replacement therapy: Technology and outcomes – A narrative review. Adv Chronic Kidney Dis. 1 janv 2021;28(1):29-36.
37.
OstermannMLumlertgulN. Acute kidney injury in ECMO patients. Crit Care. 31 août 2021;25(1):313.
38.
SeguinPLaviolleBIsslameSCouéAMallédantY. Effectiveness of simple daily sensitization of physicians to the duration of central venous and urinary tract catheterization. Intensive Care Med. juill 2010;36(7):1202-1206.
39.
Groupe d’experts, Van VongLOsmanDVinsonneauC. Épuration extrarénale en réanimation adulte et pédiatrique. Recommandations formalisées d’experts sous l’égide de la Société de réanimation de langue française (SRLF), avec la participation de la Société française d’anesthésie-réanimation (Sfar), du Groupe francophone de réanimation et urgences pédiatriques (GFRUP) et de la Société francophone de dialyse (SFD): Société de réanimation de langue française. Experts Recommandations. Réanimation. nov 2014;23(6):714-737.
40.
AllynJFerdynusCLo PintoH, et al.Complication patterns in patients undergoing venoarterial extracorporeal membrane oxygenation in intensive care unit: Multiple correspondence analysis and hierarchical ascendant classification. PLoS ONE. 11 sept 2018;13(9):e0203643.
41.
JoannidisMOudemans-van StraatenHM. Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care. 2007;11(4):218.
42.
YavariMBeckerRC. Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass. J Thromb Thrombolysis. janv 2009;27(1):95-104.
43.
KashaniKOstermannM. Optimizing renal replacement therapy for patients who need extracorporeal membrane oxygenation: Cross-talk between two organ support machines. BMC Nephrol. 13 nov 2019;20(1):404.
44.
MuriithiEWBelcherPRRaoJNChaudhryMANicolDWheatleyDJ. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass. J Thorac Cardiovasc Surg. sept 2000;120(3):538-543.
45.
de TymowskiCDesmardMLortat-JacobB, et al.Impact of connecting continuous renal replacement therapy to the extracorporeal membrane oxygenation circuit. Anaesth Crit Care Pain Med. 1 déc 2018;37(6):557-564.
46.
ThyMAugustinPTran-DinhAMontraversPDe TymowskiC. Renal replacement therapy for patients requiring extracorporeal membrane oxygenation: A multicenter international survey. Blood Purif. 2022;51(11):899-906.
47.
TrentLLawJGrimaldiD. Create intensive care green teams, there is no time to waste. Intensive Care Med. 1 avr 2023;49(4):440-443.
48.
RajsicSBreitkopfRJadzicDPopovic KrnetaMTauberHTremlB. Anticoagulation strategies during extracorporeal membrane oxygenation: A narrative review. J Clin Med. 31 août 2022;11(17):5147.
49.
NappLCKühnCBauersachsJ. ECMO In cardiac arrest and cardiogenic shock. Herz. févr 2017;42(1):27-44.
50.
HoranTCAndrusMDudeckMA. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. juin 2008;36(5):309-332.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
